3rd Quarter - Report

SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.) for SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.)

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions related to the IPAB

LobbyistCovered position, as disclosed
ENGEL BURNS —
ANTHONY MAGNETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

General patent reform initiatives (no specific bill #)

LobbyistCovered position, as disclosed
ENGEL BURNS —
ANTHONY MAGNETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues regarding Medicare Part D, Medicare reimbursement issues

LobbyistCovered position, as disclosed
ENGEL BURNS —
ANTHONY MAGNETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Discussions related to deficit reduction (no specific legislation)

LobbyistCovered position, as disclosed
ENGEL BURNS —
ANTHONY MAGNETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.